Toxoplasma gondii
|
Antigen discovery |
Whole parasite cDNA and stage-specific gene collections |
Identification of a large panel of antigens containing B- and T-cell epitopes |
[38,46,47] |
Toxoplasma gondii
|
Development of diagnostic immunoassays |
Whole parasite cDNA and stage-specific gene collections |
Assay prototypes for diagnosis of congenital toxoplasmosis in pregnant women and infants |
[63,64,65] |
Toxoplasma gondii
|
Development of DNA-based vaccines |
Stage-specific gene collections |
DNA vaccines conferring protective immunity against chronic toxoplasmosis |
[48,66,68] |
Streptococcus pneumoniae
|
Antigen discovery for vaccine development |
Genomic DNA |
Identification of a large panel of immunodominant antigens |
[52] |
Streptococcus pneumoniae
|
Epitope mapping |
Genomic DNA |
Isolation and characterization of streptococci conserved epitopes |
[53] |
Mycoplasma pneumoniae
|
Antigen discovery for diagnostic applications |
Genomic DNA |
Isolation and characterization of B-cell regions for diagnostic immunoassays |
[56,69] |
Human cytomegalovirus (HCMV) |
Antigen discovery |
Genomic DNA |
Identification of a large panel of B-cell epitopes |
[57] |
Human Hepatis C Virus (HCV) |
Antigen discovery |
Whole viral cDNA |
Molecular dissection of the B-cell response |
[29] |